127 related articles for article (PubMed ID: 314368)
21. [Variations of B- and T-lymphocytes in the peripheral blood and variations of the stimulability of cyclic nucleotides in the T-lymphocytes of patients suffering from malignant melanoma (author's transl)].
Busse E; Rose H; Lehnert W
Dermatol Monatsschr; 1979 Sep; 165(9):634-41. PubMed ID: 230989
[TBL] [Abstract][Full Text] [Related]
22. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
[TBL] [Abstract][Full Text] [Related]
23. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
24. [Effect of calf thymus extracts on the surface structure and the lysosomal apparatus of lymphocytes in patients with chronic lymphatic leukemia].
Aleksandrowicz J; Blicharski J; Cichocki T; Dobrowolski J; Kwiatkowski A; Lisiewicz J; Sasiadek U; Skotnicki AB; Wazewska-Czyzewska M
Acta Haematol Pol; 1976; 7(3):179-88. PubMed ID: 983665
[TBL] [Abstract][Full Text] [Related]
25. [Peripheral blood lymphocytes in melanoma].
Luchenko IM
Vopr Onkol; 1977; 23(2):53-6. PubMed ID: 300944
[TBL] [Abstract][Full Text] [Related]
26. Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma.
Campillo JA; Martínez-Escribano JA; Minguela A; López-Alvarez R; Marín LA; García-Alonso AM; Bensussan A; Alvarez-López MR
Dermatology; 2007; 214(4):283-8. PubMed ID: 17460398
[TBL] [Abstract][Full Text] [Related]
27. Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.
Bernengo MG; Lisa F; Meregalli M; Doveil GC
Int J Tissue React; 1984; 6(6):505-11. PubMed ID: 6335712
[TBL] [Abstract][Full Text] [Related]
28. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of some types of lymphocytes in peripheral blood of patients with bronchial asthma.
Egorova M
Allergol Immunopathol (Madr); 1983; 11(6):445-50. PubMed ID: 6608257
[TBL] [Abstract][Full Text] [Related]
30. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
Dopp AC; Mutchnick MG; Goldstein AL
Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
[TBL] [Abstract][Full Text] [Related]
31. The effect of calf thymus extract (TFX) on human T lymphocyte and neutrophil mobility and chemotactic response in vitro.
Smogorzewska EM; Korczyńska M; Gołebiowska H
Thymus; 1985; 7(4):257-60. PubMed ID: 3876625
[TBL] [Abstract][Full Text] [Related]
32. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
Sansoni P; Rossetti A; Valente G; Butturini U
Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
[No Abstract] [Full Text] [Related]
33. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
[TBL] [Abstract][Full Text] [Related]
34. Indomethacin enhancement of immunocompetence in melanoma patients.
Tilden AB; Balch CM
Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
[TBL] [Abstract][Full Text] [Related]
35. Enhancement by TP-1, a thymic extract, of pokeweed mitogen-induced differentiation of B cells from normal subjects but not of those from patients with systemic lupus erythematosus.
Fiorilli M; Sirianni MC; Pandolfi F; Pucillo LP; Letta T; Aiuti F
Thymus; 1982 Jan; 4(1):1-7. PubMed ID: 6977207
[TBL] [Abstract][Full Text] [Related]
36. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
37. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.
Jackson TM; Zaman SN
Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624
[TBL] [Abstract][Full Text] [Related]
38. Active T-rosette-forming cells in the peripheral blood of cancer patients.
Kerman RH; Smith R; Stefani SS; Ezdinili EZ
Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
[TBL] [Abstract][Full Text] [Related]
39. Bioassay for thymic extracts: guinea pig spleen lymphocytes-rabbit red blood cells rosette method.
Falchetti R; Cafiero C; Caprino L
Cancer Biochem Biophys; 1979; 4(2):69-74. PubMed ID: 552908
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
Ghossein RA; Coit D; Brennan M; Zhang ZF; Wang Y; Bhattacharya S; Houghton A; Rosai J
Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
